PNS356 PAYERS RELATED ISSUES ARISING FROM THE DEVELOPMENT OF PHARMACEUTICAL PRODUCTS AT PRE-LAUNCH.

Authors :: Fatoye, C.
Sendyona, S.
Fatoye, F.
Odeyemi, I.
Source :: Value in Health. 2019 Supplement 3, Vol. 22, pS824-S824. 1p.
Publication Year :: 2019
Abstract: Pre-launch stage of pharmaceutical product development consists of 3 components; Target Product Profile (TPP), Product Development Plan (PDP) and Design of Clinical Trials (DOCT). Stakeholders are to work on evidence generation requirements at DOCT level, and should focus on payers' issues at PDP level and at TPP level. [Extracted from the article]

Full Text Access

Tools